Ahn Seungkirl, Nelson Christopher D, Garrison Tiffany Runyan, Miller William E, Lefkowitz Robert J
The Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710, USA.
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1740-4. doi: 10.1073/pnas.262789099. Epub 2003 Feb 11.
Beta-arrestins bind to activated G protein-coupled receptor kinase-phosphorylated receptors, which leads to their desensitization with respect to G proteins, internalization via clathrin-coated pits, and signaling via a growing list of "scaffolded" pathways. To facilitate the discovery of novel adaptor and signaling roles of beta-arrestins, we have developed and validated a generally applicable interfering RNA approach for selectively suppressing beta-arrestins 1 or 2 expression by up to 95%. Beta-arrestin depletion in HEK293 cells leads to enhanced cAMP generation in response to beta(2)-adrenergic receptor stimulation, markedly reduced beta(2)-adrenergic receptor and angiotensin II receptor internalization and impaired activation of the MAP kinases ERK 1 and 2 by angiotensin II. This approach should allow discovery of novel signaling and regulatory roles for the beta-arrestins in many seven-membrane-spanning receptor systems.
β-抑制蛋白与活化的G蛋白偶联受体激酶磷酸化的受体结合,这导致它们对G蛋白脱敏、通过网格蛋白包被小窝内化以及通过越来越多的“支架”途径进行信号传导。为了促进对β-抑制蛋白新的衔接子和信号传导作用的发现,我们开发并验证了一种普遍适用的干扰RNA方法,可选择性地将β-抑制蛋白1或2的表达抑制高达95%。HEK293细胞中β-抑制蛋白的缺失导致在β₂-肾上腺素能受体刺激下cAMP生成增强、β₂-肾上腺素能受体和血管紧张素II受体的内化明显减少以及血管紧张素II对丝裂原活化蛋白激酶ERK 1和2的激活受损。这种方法应该能够发现β-抑制蛋白在许多七跨膜受体系统中的新信号传导和调节作用。